An efficient screening life cycle assessment evaluates environmental impacts of dialysis treatments, indicating feasibility for manufacturers.
The scLCA makes performing environmental assessments more feasible for manufacturers while generating results comparable to 'comprehensive' LCAs.
No takes yet. Share an insight, caveat, or question.
Seemann et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: